Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCP-Tacro for Tremor in Kidney Transplant (STRATO)
NCT01438710Phase 3Completed
- Sponsor
- Veloxis Pharmaceuticals
- Start
- Dec 2011
- Primary completion
- Aug 2012
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Envarsus XR in kidney transplant rejection, sponsored by Veloxis Pharmaceuticals. Started Dec 2011; status: completed.
02
Drugs
Envarsus XR
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01438710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438710.